Pharma Business Week articles from January 2003

Pharma Business Week archives from January 2003

New data suggest a prolongation of time off HAART without significant viral rebound.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Hemispherx Biopharma, Inc., (HEB) presented new data from a phase IIB clinical trial of its experimental compound, RNA-based Ampligen, on Structured Treatment Interruption (STI) in HIV. Gary...

Phase II study with huN901-DM1 set to begin.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- ImmunoGen, Inc., (IMGN) announced that British Biotech is starting the phase II portion of the phase I/II study being conducted in the United States with huN901-DM1 (BB-10901), a monoclonal...

Pharmaceutical product launch period critical to commercial success.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Brand teams expend 34% of their total budgets during launch, a 12% increase over phase IIIa spending, according to a new report from business intelligence firm Cutting Edge Information. Marketing...

ISIS 113715 reacquired from Merck.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) announced that it has reacquired full product rights to ISIS 113715, its preclinical type 2 diabetes antisense drug candidate, from Merck & Co., Inc., (MRK). ...

Spek takes responsibility for the worldwide operations.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- As from January 1, 2003, Hanspeter Spek, executive vice president, will be in charge of the worldwide operations of Sanofi-Synthelabo, and appointed chairman of the U.S. subsidiary. In order to...

Drug discovery, development collaboration renewed.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Icagen, Inc., announced the renewal of its research and development agreement with Bristol-Myers Squibb Company (BMY) for the discovery and development of small molecule drugs targeting a specific ion...

Ephedra-based products discontinued.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Health & Nutrition Systems International, Inc., (HNNS) was informed by its exclusive manufacturer that effective December 31, 2002 they will be unable to supply the company with ephedra-based products...

Vectura signs dry powder drug formulation deal, secures additional funding.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Vectura, Ltd., (Vectura) announced that it has signed an agreement with GlaxoSmithKline, plc, (GSK) to collaborate on evaluating Vectura's Aerocine and associated powder formulation technologies in dry...

eResearchTechnology announces multiple EDC trial agreements.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- eResearchTechnology (eRT), Inc., (ERES) an e-research technology and services provider, announced that it has executed a subscription agreement with a top 10 global pharmaceutical enterprise to provide...

Pegasys in combination with Copegus approved in the U.S.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Roche announced that the U.S. Food and Drug Administration (FDA) has approved combination therapy with Pegasys (peginterferon alfa-2a) and Copegus (Roche's ribavirin) for the treatment of hepatitis C....

Company updates on Darvon/Darvocet-N performance, reiterates guidance.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- aaiPharma (AAII) recapped presentations from an investor meeting and public webcast - held in San Francisco, California and via the company's web site - during which management provided an update...

Motion Computing, Pharmedica announce tablet PC-based education initiative.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Motion Computing and Pharmedica Holdings, LLC, announced a collaboration to enhance the way pharmaceutical sales representatives interact with physicians. Pharmedica will use the new Motion M1200...

Vancouver General chooses Omnicell for automated pharmacy dispensing.
January 27, 2003... 2003 JAN 27 - (NewsRx.com & NewsRx.net) -- Vancouver General Hospital (VGH), a 571-bed teaching and research facility, has purchased $2.5 million (Canadian) in pharmacy automation systems from Omnicell (MCL), based in Palo Alto, California. ...